Heron Therapeutics
HRTX
#7354
Rank
NZ$0.62 B
Marketcap
$4.08
Share price
-3.29%
Change (1 day)
-16.91%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.03. In 2022 the company made an earnings per share (EPS) of -$3.01 an increase over its 2021 EPS that were of -$3.91.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-35.58%
2022-$3.01-23.11%
2021-$3.91-10%
2020-$4.34-0%
2019-$4.341.21%
2018-$4.29-32.7%
2017-$6.38-19.34%
2016-$7.9154.76%
2015-$5.111.73%
2014-$5.02-16.23%
2013-$6.0091.67%
2012-$3.13-31.45%
2011-$4.56-27.06%
2010-$6.26-43.75%
2009-$11.12-57.33%
2008-$26.07-82.92%
2007-$152.6020.61%
2006-$126.53175.76%
2005-$45.88-21.43%
2004-$58.40100%
2003-$29.20-38.24%
2002-$47.27161.54%
2001-$18.08-106.46%
2000$279.642051.55%
1999$13.00839.73%
1998$1.38-105.48%
1997-$25.26-88.16%
1996-$213.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.26-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.24-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.83 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.73-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.87 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA